Dr. Paul Sax takes a more detailed look at why a treatment of extensive NRTI resistance is still controversial in
HIV and ID Observations.
The SWITCHMRK trial had a profound impact on how ID doctors managed virologically suppressed patients for years. In the latest HIV and ID Observations, Dr. Paul Sax cites a recent case to see if the results of SWITCHMRK still apply to HIV today.
Do you want to be notified whenever Dr. Sax posts? Sign up to receive notifications by email by using the Subscribe box.
Want to see more from NEJM Journal Watch? Register here.